Kefir Versus Milk on Time-Trial Performance in Masters Athletes
NCT ID: NCT06165523
Last Updated: 2023-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2023-03-07
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water
Water
Water
340 mL plain tap water consumed immediately following glycogen depleting exercise
Flavored Kefir
1% Lowfat Kefir manufactured by Lifeway Kefir and containing 18 g of CHO, 10 g of protein, and 2 g of fat
Flavored Kefir
320 mL kefir consumed immediately following glycogen depleting exercise
Flavored Milk
1% Lowfat Milk manufactured by Prairie Farms and containing 24 g of CHO, 8 g of protein, and 2.5 g of fat
Flavored Milk
240 mL flavored milk consumed immediately following glycogen depleting exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Water
340 mL plain tap water consumed immediately following glycogen depleting exercise
Flavored Kefir
320 mL kefir consumed immediately following glycogen depleting exercise
Flavored Milk
240 mL flavored milk consumed immediately following glycogen depleting exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be in good health as determined by medical history and routine blood chemistries.
* Normotensive (seated, resting systolic blood pressure \< 140 mm Hg and diastolic blood pressure \< 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5 minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility.
* Normal seated, resting heart rate (\< 90 beats per minute).
* Age between 40 and 75 years of age
* Body Mass Index \<30 kg/m2 or Body Fat \<30% for females and \<25% for males
* Performing aerobic exercise \> 150 mins/week and training for at least 3 years
* Well-trained will be defined as athletes that meet two of the four following criteria: training frequency is 3-7 sessions/week; duration of training sessions is 60-240 min; training background is at least 3 y; race frequency is at least once a year.
Exclusion Criteria
* Individuals currently diagnosed with or are being treated for celiac disease, lactose intolerance, digestive insufficiencies or other gastrointestinal complications such as irritable bowel syndrome, ulcerative colitis, etc.
Alcohol consumption (more than 2 standard alcoholic drinks per day or more than 10 drinks per week) or drug abuse or dependence.
* Smokers or individuals who have quit smoking within the last 6 months
* Participants that are unwilling to refrain from caffeine, nicotine, and alcohol intake for 12 hours prior to each study visit.
* Known sensitivity to any ingredient in the test formulations as listed in the Nutrition Facts label.
* Individuals who are determined to be on a ketogenic diet.
* Individuals who are cognitively impaired and/or who are unable to give informed consent.
* Participants that are unwilling to refrain from taking biotin at a minimum of 72 hours before visit 3 through the end of the study due to potential interference with laboratory analyses.
* Individuals taking a medication known to impact digestive function or hormonal functions that may impact how our body digests, absorbs or metabolizes nutrients
* Individuals that are currently taking a probiotic or a dietary supplement that may impact digestive function or hormonal function that may impact how our body digests, absorbs or metabolizes nutrients
* Participants that are unwilling to refrain from fermented foods and yogurt, as well as maintain normal consumption levels of prebiotics throughout the study.
* Pregnant women, women trying to become pregnant, or nursing women.
* Individuals who indicate they are actively restricting calories or attempting to lose weight.
* Participants that are unwilling to keep their self-directed training protocols the same throughout the course of the study
* Participants that are unwilling to wear the same shoes and similar clothing for all testing visits.
* Individuals who participate in aerobic exercise \< 2 days/week or have been aerobically training \< 3 years
* Individuals that do not meet the criteria to be defined as well-trained
* Unwillingness to intake a supplement or follow the study protocol
* Any other condition which in the investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose a significant risk to the subject.
40 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lindenwood University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chad M Kerksick, PhD
Role: PRINCIPAL_INVESTIGATOR
Lindenwood University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exercise and Performance Nutrition Laboratory
Saint Charles, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-23-71
Identifier Type: -
Identifier Source: org_study_id